Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChargePoint Technology is a leading specialist in the development and manufacture of containment and sterile transfer solutions for the pharmaceutical, biotech, and chemical industries. The company is best known for its Split Butterfly Valve (SBV) technology, which ensures the safe and sterile transfer of highly potent active pharmaceutical ingredients (HPAPIs) and sensitive powders. Their products, such as the PharmaSafe and AseptiSafe ranges, are critical for maintaining operator safety and product integrity during the manufacturing process. Headquartered in Liverpool, UK, ChargePoint serves a global client base of major pharmaceutical manufacturers and contract development and manufacturing organizations (CDMOs). In 2024, the company was acquired by Rotork plc, a global provider of mission-critical flow control and instrumentation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChargePoint Technology.